Introducing MyAchonJourney: A New Resource for Families
BridgeBio Pharma, Inc. (Nasdaq: BBIO), a prominent biopharmaceutical company focused on addressing genetic diseases, has launched an innovative platform named MyAchonJourney. This online resource is designed to support individuals and families affected by achondroplasia.
What is Achondroplasia?
Achondroplasia is a prevalent form of skeletal dysplasia, which results in impaired growth of bones and cartilage. Those impacted by achondroplasia often encounter a variety of challenges, including physical adaptations and social interactions. The introduction of MyAchonJourney aims to address these challenges by offering tailored information and support specifically for families.
Insights from Experts on MyAchonJourney
Dr. William Mackenzie, Emeritus Chairman of the Department of Orthopedic Surgery at Nemours Children’s Health, shared, "MyAchonJourney helps bridge the gap between medical care and everyday life experiences. This comprehensive resource is designed to empower families with knowledge about the medical aspects of achondroplasia, ensuring that their children can thrive and lead fulfilling lives."
The Comprehensive Features of MyAchonJourney
The initial phase of MyAchonJourney is thoughtfully crafted to provide ongoing support for families with children diagnosed with achondroplasia. It offers guidance on navigating essential medical topics, psychosocial concerns, and quality-of-life adjustments during the early years of a child's life, focusing on:
- Pregnancy and Birth: Information on pre-birth diagnosis, preparing for the baby's arrival, and what to expect during the first days at home.
- Infancy and Toddlerhood (Birth-2 Years): Advice on potential medical issues, early developmental milestones, home modifications, and advocacy for parents.
- Early Childhood (3-5 Years): Support in identifying mobility aids, adaptations at home and school, and psychosocial resources.
Looking Ahead: Future Developments of MyAchonJourney
Future phases of MyAchonJourney will broaden its scope to include resources for older children, teenagers, and young adults. This ongoing initiative demonstrates a strong commitment to continually enhancing the support available for families affected by achondroplasia.
Collaboration within the Community
Anne Lee Grumet, Sr. Director of Global Patient Advocacy at QED Therapeutics, highlighted the importance of fostering education and awareness beyond treatment. "We are grateful to our community for their collaborative efforts in creating a resource that empowers families to navigate all aspects of life with achondroplasia," she remarked.
Acknowledging Contributors to MyAchonJourney
Special thanks are due to the dedicated task force that provided invaluable insights during the development of MyAchonJourney:
- Chandler Crews, Founder, The Chandler Project
- Colleen Gioffreda, Clinical Operations Program Administrator, Johns Hopkins University
- Deborah Krakow, M.D., Professor at UCLA
- Kimberly Fine, M.S., OTR/L, Occupational Therapist
- Kristen DeAndrade, Founder, Little Legs Big Heart Foundation
- Mari Groves, M.D., Associate Professor at Johns Hopkins Hospital
- Michelle Kraus, MSW, Senior Social Worker
- Munira Shamim, J.D., Co-Founder of Growing Stronger
- William Mackenzie, M.D., Emeritus Chairman, Nemours Children’s Health
About BridgeBio Pharma
BridgeBio Pharma is recognized for developing transformative medicines aimed at treating genetic diseases. Founded in 2015, the company is dedicated to leveraging its expertise in drug discovery and development to accelerate the delivery of innovative therapies to patients. For the latest updates, the company's website and social media channels will serve as primary sources for news and developments.
Contact Information
BridgeBio Pharma, Inc. Contact:
Vikram Bali
Contact: contact@bridgebio.com
(650)-789-8220
QED Contact:
Anne Lee Grumet
Sr. Director, Global Patient Advocacy
Email: PatientAdvocacyQED@bridgebio.com
Frequently Asked Questions
1. What is MyAchonJourney?
MyAchonJourney is an online platform developed by BridgeBio Pharma to assist individuals and families affected by achondroplasia.
2. Who can benefit from MyAchonJourney?
This resource is primarily intended for families of children with achondroplasia, but it is also set to evolve to support older children, teenagers, and young adults.
3. What topics are included in the initial phase?
The initial phase covers guidance on pregnancy, birth, infancy, and early childhood developmental challenges associated with achondroplasia.
4. How does BridgeBio support the community?
BridgeBio collaborates with community members to provide educational resources that empower families in managing life with achondroplasia.
5. How can families reach out to BridgeBio for more information?
Families can contact BridgeBio at contact@bridgebio.com or call (650)-789-8220 for any inquiries regarding MyAchonJourney.
